Back to mobile site

HeartWare (HTWR) Prelim. Q4 Revenue Misses Views

January 14, 2014 4:50 PM EST Send to a Friend
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login